{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:42:38Z","timestamp":1755999758149},"reference-count":32,"publisher":"Elsevier","isbn-type":[{"value":"9780081000946","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/b978-0-08-100094-6.00010-9","type":"book-chapter","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T20:41:05Z","timestamp":1443818465000},"page":"155-167","source":"Crossref","is-referenced-by-count":4,"title":["Cell-based in vitro models for\u00a0dermal permeability studies"],"prefix":"10.1016","author":[{"given":"Francisca","family":"Rodrigues","sequence":"first","affiliation":[]},{"given":"Maria Beatriz P.P.","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/B978-0-08-100094-6.00010-9_bib1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1523-1747.2000.00869.x","article-title":"Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS","volume":"114","author":"Allen-Hoffmann","year":"2000","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"10.1016\/B978-0-08-100094-6.00010-9_bib2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0305-4179(01)00018-3","article-title":"Skin substitutes: a review","volume":"27","author":"Balasubramani","year":"2001","journal-title":"Burns"},{"issue":"4","key":"10.1016\/B978-0-08-100094-6.00010-9_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9610(02)00813-9","article-title":"Principles and practices for treatment of cutaneous wounds with cultured skin substitutes","volume":"183","author":"Boyce","year":"2002","journal-title":"The American Journal of Surgery"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00010-9_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1755-148X.2010.00786.x","article-title":"Artificial skin in perspective: concepts and applications","volume":"24","author":"Brohem","year":"2011","journal-title":"Pigment Cell & Melanoma Research"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00010-9_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tiv.2009.11.010","article-title":"In vitro assessment of eye irritancy using the Reconstructed Human Corneal Epithelial SkinEthic\u2122 HCE model: application to 435 substances from consumer products industry","volume":"24","author":"Cotovio","year":"2010","journal-title":"Toxicology In Vitro"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00010-9_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000066680","article-title":"Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or \u03b1-tocopherol applied on human skin models or human skin ex vivo at finite doses","volume":"15","author":"Dreher","year":"2002","journal-title":"Skin Pharmacology and Physiology"},{"key":"10.1016\/B978-0-08-100094-6.00010-9_bib7","series-title":"Guidance document on dermal absorption","year":"2004"},{"key":"10.1016\/B978-0-08-100094-6.00010-9_bib8","series-title":"Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients","year":"2006"},{"key":"10.1016\/B978-0-08-100094-6.00010-9_bib9","series-title":"ESAC statement on the scientific validity of an iEURL ECVAM progress report on the development, validation and regulatory acceptance of alternative methods (2010-2013)n-vitro test method for skin corrosivity testing","year":"2013"},{"key":"10.1016\/B978-0-08-100094-6.00010-9_bib10","series-title":"Guidance for industry: SUPAC-SS in vitro release testing and in vivo bioequivalence documentation","year":"1997"},{"issue":"4","key":"10.1016\/B978-0-08-100094-6.00010-9_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/10454411960070040101","article-title":"Keratinocytes and cytokine\/growth factors","volume":"7","author":"Feliciani","year":"1996","journal-title":"Critical Reviews in Oral Biology & Medicine"},{"issue":"11","key":"10.1016\/B978-0-08-100094-6.00010-9_bib12","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.addr.2007.07.004","article-title":"Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models","volume":"59","author":"Godin","year":"2007","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"3","key":"10.1016\/B978-0-08-100094-6.00010-9_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jbmt.2008.03.005","article-title":"Fibroblast mechanics in three-dimensional collagen matrices","volume":"12","author":"Grinnell","year":"2008","journal-title":"Journal of Bodywork and Movement Therapies"},{"issue":"5","key":"10.1016\/B978-0-08-100094-6.00010-9_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/mp800047v","article-title":"3-D tumor model for in vitro evaluation of anticancer drugs","volume":"5","author":"Horning","year":"2008","journal-title":"Molecular Pharmaceutics"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00010-9_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.toxlet.2009.03.019","article-title":"Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm\u2122 human reconstructed epidermis model","volume":"188","author":"Hu","year":"2009","journal-title":"Toxicology Letters"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00010-9_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejpb.2007.05.003","article-title":"In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use","volume":"68","author":"Lombardi Borgia","year":"2008","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00010-9_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12263-008-0107-0","article-title":"Modelling tissues in 3D: the next future of pharmaco-toxicology and food research?","volume":"4","author":"Mazzoleni","year":"2009","journal-title":"Genes & Nutrition"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00010-9_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2005.03.004","article-title":"The human epidermis models EpiSkin\u00ae, SkinEthic\u00ae and EpiDerm\u00ae: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport","volume":"60","author":"Netzlaff","year":"2005","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/B978-0-08-100094-6.00010-9_bib19","series-title":"Guidance document for the conduct of skin absorption studies","year":"2004"},{"key":"10.1016\/B978-0-08-100094-6.00010-9_bib20","unstructured":"OECD (2004b). Test No. 431: In vitro skin corrosion: Human skin model test. OECD guidelines for the testing of chemicals, section 4. OECD Publishing."},{"key":"10.1016\/B978-0-08-100094-6.00010-9_bib21","unstructured":"OECD (2013). Test No. 439: In vitro skin irritation. OECD Publishing."},{"issue":"1\u20132","key":"10.1016\/B978-0-08-100094-6.00010-9_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-5173(00)00459-2","article-title":"Lipid and ultrastructural characterization of reconstructed skin models","volume":"203","author":"Ponec","year":"2000","journal-title":"Internation Journal of Pharmaceutics"},{"issue":"7","key":"10.1016\/B978-0-08-100094-6.00010-9_bib23","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.tiv.2010.07.027","article-title":"The StrataTest\u00ae human skin model, a consistent in vitro alternative for toxicological testing","volume":"24","author":"Rasmussen","year":"2010","journal-title":"Toxicology In Vitro"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00010-9_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1467-2494.1999.183571.x","article-title":"Potential cosmetic applications of reconstructed epidermis","volume":"21","author":"Regnier","year":"1999","journal-title":"International Journal of Cosmetic Science"},{"issue":"6","key":"10.1016\/B978-0-08-100094-6.00010-9_bib25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/BF02518889","article-title":"Reconstructed human epidermis composed of keratinocytes, melanocytes and Langerhans cells","volume":"36","author":"R\u00e9gnier","year":"1998","journal-title":"Medical and Biological Engineering and Computing"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00010-9_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000066681","article-title":"The use of standardized human skin models for cutaneous pharmacotoxicology studies","volume":"15","author":"Roguet","year":"2002","journal-title":"Skin Pharmacology and Physiology"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00010-9_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejpb.2008.10.004","article-title":"Simultaneous absorption of vitamins C and E from topical microemulsions using reconstructed human epidermis as a skin model","volume":"72","author":"Rozman","year":"2009","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"5","key":"10.1016\/B978-0-08-100094-6.00010-9_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/17425255.2012.673586","article-title":"Cell-based in vitro models for predicting drug permeability","volume":"8","author":"Sarmento","year":"2012","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/B978-0-08-100094-6.00010-9_bib29","first-page":"3","article-title":"Models for skin absorption and skin toxicity testing","volume":"Vol. VII","author":"Schaefer","year":"2008"},{"issue":"6","key":"10.1016\/B978-0-08-100094-6.00010-9_bib30","first-page":"559","article-title":"The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test","volume":"35","author":"Spielmann","year":"2007","journal-title":"ATLA: Alternatives to Laboratory Animals"},{"issue":"4","key":"10.1016\/B978-0-08-100094-6.00010-9_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clindermatol.2004.07.023","article-title":"Engineered skin substitutes: practices and potentials","volume":"23","author":"Supp","year":"2005","journal-title":"Clinics in Dermatology"},{"issue":"6","key":"10.1016\/B978-0-08-100094-6.00010-9_bib32","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1365-2133.2007.07914.x","article-title":"The role of fibroblasts in tissue engineering and regeneration","volume":"156","author":"Wong","year":"2007","journal-title":"British Journal of Dermatology"}],"container-title":["Concepts and Models for Drug Permeability Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780081000946000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780081000946000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T23:57:19Z","timestamp":1537315039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780081000946000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780081000946"],"references-count":32,"URL":"https:\/\/doi.org\/10.1016\/b978-0-08-100094-6.00010-9","relation":{},"subject":[],"published":{"date-parts":[[2016]]}}}